Compliance to Vaginal Dilation Therapy in Patients Who Have Undergone Radiation Therapy For Stage IB, Stage IIA, Stage IIB, Stage IIIA, or Stage IIIB Cervical Cancer or Stage IA, Stage IB, Stage IIA, or Stage IIB Endometrial Cancer - NCT00735514-44708 (Clinical Trial 236665)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy236665.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Cleveland |
|
State:
|
|
OH |
| Zip Code: |
|
44708 |
| Conditions: |
|
Cervical Cancer - Endometrial Cancer - Radiation Toxicity - Sexuality and Reproductive Issues |
| Purpose: |
|
RATIONALE: Understanding how well patients comply with their treatment regimen may help
doctors determine best treatment and ongoing care for future patients.
PURPOSE: This phase I study is looking at compliance with vaginal dilation therapy in women
who have undergone radiation therapy for stage IB, stage IIA, stage IIB, stage IIIA, or
stage IIIB cervical cancer or stage IA, stage IB, stage IIA, or stage IIB endometrial
cancer.
|
| Study summary: |
|
OBJECTIVES:
Primary
- To determine adherence to vaginal dilation therapy after radiotherapy in patients with
early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB endometrial cancer.
- To identify demographic, medical, and psychosocial factors associated with adherence to
recommendations for vaginal dilation in these patients.
- To describe the sexual, marital, and non-marital dyadic functioning of these patients.
OUTLINE: Patients from the IMPAC registry in Radiation Oncology at the University Hospitals
Case Medical Center, Ireland Cancer Center complete questionnaires online or by mail.
Questionnaires include the Vaginal Dilation Adherence questionnaire, the Sexual
Function-Vaginal Changes Questionnaire, the Dyadic Satisfaction questionnaire, and the
Physician/Nurse Recommendation of Vaginal Dilation questionnaire. |
| Criteria: |
|
DISEASE CHARACTERISTICS:
- History of early-stage IB grade 2-IIIB cervical cancer or stage IA grade 3-IIB
endometrial cancer
- Meets the following criteria:
- Received radiotherapy for this disease
- Treated within the last 3 years and followed for at least 6 months
PATIENT CHARACTERISTICS:
- Able to read and understand English
- Currently with or without a sexual partner
- No history of other cancers
- No other potentially life-threatening disease
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics |
|
|
|
| Study is available at: |
|
Mercy Cancer Center at Mercy Medical Center
Cleveland, OH 44708
United States
Primary Contact:
Lois Friedman
Phone: 216-844-1361 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 16, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|